Lantern Pharma Inc (LTRN)

Sep 30, 2025

FDA Guidance Advances Lantern Pharma's Pediatric Brain Cancer Therapy Toward 2026 Clinical Trial - citybuzz -

Sep 30, 2025

Sep 30, 2025

Using flow based indicators on Lantern Pharma Inc.July 2025 Summary & Expert Approved Trade Ideas - newser.com

Sep 30, 2025

Sep 30, 2025

Is Lantern Pharma Inc. stock a buy for dividend growthJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com

Sep 30, 2025

Sep 29, 2025

What’s the recovery path for long term holders of Lantern Pharma Inc.Market Sentiment Review & Long-Term Growth Plans - newser.com

Sep 29, 2025

Sep 29, 2025

Lantern Pharma Inc.’s volatility index tracking explained2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com

Sep 29, 2025

Sep 29, 2025

Lantern Pharma Inc. stock prediction for this week2025 Growth vs Value & Weekly Market Pulse Updates - newser.com

Sep 29, 2025

Sep 29, 2025

Two stocks to invest in the future of pharma | 2025-09-29 | Investing News - Stockhouse

Sep 29, 2025

Sep 29, 2025

Why Lantern Pharma Inc. is moving todayJuly 2025 Technicals & High Accuracy Trade Signal Alerts - newser.com

Sep 29, 2025

Sep 28, 2025

What analysts say about Lantern Pharma Inc stockRisk Adjusted Returns & Free Unlock Portfolio Growth - earlytimes.in

Sep 28, 2025

Sep 28, 2025

What drives Lantern Pharma Inc stock priceEconomic Indicators Overview & Small Budget Capital Investment - earlytimes.in

Sep 28, 2025

Sep 27, 2025

Is Lantern Pharma Inc. showing signs of accumulationJuly 2025 Action & Weekly High Potential Alerts - newser.com

Sep 27, 2025

Sep 24, 2025

Lantern Pharma Holds Annual Stockholders Meeting - TipRanks

Sep 24, 2025

Sep 23, 2025

Lantern Pharma shareholders elect directors and approve stock option repricing - Investing.com

Sep 23, 2025

Sep 19, 2025

Earnings Update: Can LEXX maintain its current growth ratePortfolio Performance Report & High Accuracy Investment Signals - khodrobank.com

Sep 19, 2025

Sep 19, 2025

Market Fear: Whats the beta of Lantern Pharma Inc stockAnalyst Upgrade & High Accuracy Trade Signal Alerts - khodrobank.com

Sep 19, 2025

Sep 18, 2025

Pattern recognition hints at Lantern Pharma Inc. upsideMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com

Sep 18, 2025

Sep 18, 2025

Profit Recap: How liquid is Lantern Pharma Inc. stockQuarterly Profit Report & Long-Term Growth Portfolio Plans - خودرو بانک

Sep 18, 2025

Sep 18, 2025

Recap Report: Is Cenovus Energy Inc Equity Warrant impacted by rising rates2025 Trade Ideas & Risk Managed Trade Strategies - khodrobank.com

Sep 18, 2025

Sep 18, 2025

Intraday pattern recognizer results for Lantern Pharma Inc.Market Growth Summary & Breakout Confirmation Alerts - newser.com

Sep 18, 2025

Sep 18, 2025

How to track smart money flows in Lantern Pharma Inc.Insider Selling & High Yield Stock Recommendations - newser.com

Sep 18, 2025

Sep 18, 2025

Returns Recap: Will RKDA outperform small cap indexesEarnings Growth Summary & Technical Buy Zone Confirmation - khodrobank.com

Sep 18, 2025

Sep 18, 2025

Comparing Lantern Pharma Inc. in custom built stock radarsPortfolio Growth Summary & Stepwise Trade Execution Plans - newser.com

Sep 18, 2025

Sep 17, 2025

Lantern Pharma’s LP-184 Phase 1a Clinical Trial Achieves All Primary Endpoints with Robust Safety Profile and Promising Antitumor Activity in Multiple Advanced Solid Tumors - BioSpace

Sep 17, 2025

Sep 16, 2025

Using AI based signals to follow Lantern Pharma Inc.Weekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com

Sep 16, 2025

Sep 16, 2025

Insider Sell: What are Lantern Pharma Incs recent SEC filings showingVolume Spike & Verified Entry Point Signals - khodrobank.com

Sep 16, 2025

Sep 16, 2025

Aug Spikes: Whats the beta of Lantern Pharma Inc stockEarnings Trend Report & Safe Entry Trade Signal Reports - خودرو بانک

Sep 16, 2025

Sep 16, 2025

Lantern Pharma (LTRN) Advances LP-184 with Positive Phase 1a Tri - GuruFocus

Sep 16, 2025

Sep 16, 2025

Lantern Pharma Says Phase 1a Study Of LP-184 Met All Primary Endpoints In Advanced Solid Tumors - Nasdaq

Sep 16, 2025

Sep 16, 2025

Lantern Pharma stock climbs after LP-184 cancer drug hits trial endpoints - Investing.com Canada

Sep 16, 2025

Sep 16, 2025

Aug Retail: Can Lantern Pharma Inc disrupt its industryQuarterly Profit Report & Stepwise Swing Trade Plans - خودرو بانک

Sep 16, 2025

Sep 16, 2025

What to do if you’re stuck in Lantern Pharma Inc.Risk Management & Stepwise Trade Signal Implementation - newser.com

Sep 16, 2025

Sep 15, 2025

Forecasting Lantern Pharma Inc. price range with options dataWeekly Market Summary & Low Drawdown Investment Ideas - newser.com

Sep 15, 2025

Sep 15, 2025

Will earnings trigger a reversal in Lantern Pharma Inc.Market Growth Report & Community Trade Idea Sharing - newser.com

Sep 15, 2025

Sep 15, 2025

RedChip to Host Exclusive Investor Webinar Featuring Lantern Pharma on August 26 - The Marion Star

Sep 15, 2025

Sep 14, 2025

How to use Fibonacci retracement on Lantern Pharma Inc.Portfolio Risk Summary & Expert Curated Trade Setup Alerts - newser.com

Sep 14, 2025

Sep 10, 2025

Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma Featured on IBN’s BioMedWire Podcast - Barchart.com

Sep 10, 2025

Sep 10, 2025

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Panna Sharma, CEO of AI-Driven Biotech Focused on Challenging & Rare Cancers, Lantern Pharma Inc. (LTRN) - The Manila Times

Sep 10, 2025

Sep 10, 2025

IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire

Sep 10, 2025